Product Name:3-Chloro-4-(pyridin-3-yl)-1,2,5-thiadiazole

IUPAC Name:3-(4-chloro-1,2,5-thiadiazol-3-yl)pyridine

CAS:131986-28-2
Molecular Formula:C7H4ClN3S
Purity:95%
Catalog Number:CM175538
Molecular Weight:197.64

Packing Unit Available Stock Price($) Quantity
CM175538-100mg in stock ƴř
CM175538-250mg in stock ţřŁ
CM175538-1g in stock řǎŁ
CM175538-5g in stock ƴřŁ

For R&D use only.

Inquiry Form

   refresh    

Product Details

CAS NO:131986-28-2
Molecular Formula:C7H4ClN3S
Melting Point:-
Smiles Code:ClC1=NSN=C1C1=CC=CN=C1
Density:
Catalog Number:CM175538
Molecular Weight:197.64
Boiling Point:297.197°C at 760 mmHg
MDL No:MFCD03066187
Storage:Store at 2-8°C.

Category Infos

Pyridines
Pyridine is a six-membered heterocyclic compound containing one nitrogen heteroatom. Pyridine and piperidine are the most frequently occurring heterocyclic building blocks in drug molecules. According to incomplete statistics, there are currently more than 180 drugs containing pyridine or piperidine structure that have been marketed, nearly 1/5 of the drugs approved for marketing in recent years contain these two structures.
Pyridine | C5H5N | Pyridine Supplier/Distributor/Manufacturer - Chemenu
Pyridine,Pyridine Wholesale,Pyridine for Sale,Pyridine Supplier,Pyridine Distributor,Pyridine Manufacturer
Pyridine is a basic heterocyclic organic compound with the chemical formula C5H5N. It is structurally related to benzene, with one methine group (=CH−) replaced by a nitrogen atom. It is a highly flammable, weakly alkaline, water-miscible liquid with a distinctive, unpleasant fish-like smell.
Thiadiazoles
Thiadiazoles are a subfamily of azoles. Structurally, they are five-membered heterocyclic compounds containing two nitrogen atoms and one sulfur atom, and two double bonds, forming an aromatic ring. Depending on the relative positions of the heteroatoms, there are four possible structures; these forms do not interconvert and are therefore structural isomers rather than tautomers. These compounds themselves are rarely synthesized and have no particular utility, however, compounds that use them as structural motifs are fairly common in pharmacology.

Column Infos

COBENFY
Bristol Myers Squibb announced that the FDA has approved COBENFY® (xanomeline and trospium chloride). COBENFY represents the first new class of medicine in several decades and introduces a fundamentally new approach to treating schizophrenia by selectively targeting M1 and M4 receptors in the brain without blocking D2 receptors. COBENFY® (xanomeline and trospium chloride), formerly KarXT, is an oral medication for the treatment of schizophrenia in adults. COBENFY combines xanomeline, a dual M1 - and M4 - preferring muscarinic receptor agonist, with trospium chloride, a muscarinic receptor antagonist that does not appreciably cross the blood-brain barrier, primarily acting in peripheral tissues. While the exact mechanism of action of COBENFY is unknown, its efficacy is thought to be due to the agonist activity of xanomeline at M1 and M4 muscarinic acetylcholine receptors in the central nervous system.
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.